Issue 12/2013
Content (9 Articles)
Acknowledgement to Referees
Acknowledgments
Commentary
Search MEDLINE for Economic Evaluations: Tips to Translate an OVID Strategy into a PubMed One
Mattias Neyt, Patrice X. Chalon
Current Opinion
Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US
Fred J. Hellinger
Practical Application
How to Include Informal Care in Economic Evaluations
Renske J. Hoefman, Job van Exel, Werner Brouwer
Review Article
Vemurafenib for the Treatment of Locally Advanced or Metastatic BRAF V600 Mutation-Positive Malignant Melanoma: A NICE Single Technology Appraisal
Sophie Beale, Rumona Dickson, Adrian Bagust, Michaela Blundell, Yenal Dundar, Angela Boland, Ernie Marshall, Ruth Plummer, Chris Proudlove
Systematic Review
The Estimation of Utility Weights in Cost-Utility Analysis for Mental Disorders: A Systematic Review
Michael Sonntag, Hans-Helmut König, Alexander Konnopka
Systematic Review
Cost Effectiveness of Medication Adherence-Enhancing Interventions: A Systematic Review of Trial-Based Economic Evaluations
Edwin J. M. Oberjé, Reina J. A. de Kinderen, Silvia M. A. A. Evers, Cees M. J. van Woerkum, Marijn de Bruin
Original Research Article
A Closer Look at Decision and Analyst Error by Including Nonlinearities in Discrete Choice Models: Implications on Willingness-to-Pay Estimates Derived from Discrete Choice Data in Healthcare
Esther W. de Bekker-Grob, John M. Rose, Michiel C. J. Bliemer
Erratum
Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective
Anthony Bentley, Samantha Gillard, Michael Spino, John Connelly, Fernando Tricta